Also indexed as: Acutrim®, Dex-A-Diet®,
Dexatrim®, Phenldrine®, Phenoxine®, PPA, Propagest®, Rhindecon®,
Unitrol®
Combination drugs:
Ami-Tex® LA, Appedrine®, Contac® 12 Hour, DayQuil® Allergy Relief, Dex-A-Diet® Plus Vitamin C, Diadex® Grapefruit Diet Plan, Dimetapp®,
Entex® LA, Robitussin® CF, Tavist®-D, Triaminic®-12
Phenylpropanolamine is a drug used to relieve nasal congestion due to colds, hay fever, upper
respiratory allergies, and sinusitis. It is available
in nonprescription products alone and in combination with other nonprescription drugs, to
treat symptoms of allergy, colds, and upper respiratory
infections. Phenylpropanolamine is also used as an adjunct to calorie restriction in
short-term weight loss. It is available in nonprescription products alone and in combination
with other ingredients for weight loss.
The Food and Drug Administration (FDA) has taken steps to remove phenylpropanolamine from
all drug products and has issued a public health advisory concerning phenylpropanolamine
hydrochloride. This drug is an ingredient used in many over-the-counter (OTC) and prescription
cough and cold medications as a decongestant and in OTC weight loss products. PPA has been
found to increase the risk of hemorrhagic stroke (bleeding into the brain or into tissue
surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic
stroke is very low, FDA recommends that consumers not use any products that contain PPA.
Safetychecker Summary
for Phenylpropanolamine
(for details about the summarized interactions, read the full article)
Avoid: Adverse interaction—Avoid these supplements
when taking this medication because taking them together may cause undesirable or dangerous
results. |
Caffeine
Ephedra sinica (Ma huang)*
|
| Depletion or interference |
None known
|
| Side effect reduction/prevention |
None known
|
| Supportive interaction |
None known
|
| Reduced drug
absorption/bioavailability |
None known
|
An asterisk (*) next to an item in the summary indicates that the
interaction is supported only by weak, fragmentary, and/or contradictory scientific
evidence.
Interactions with Herbs
Ephedra sinica (Ma
huang)
Ephedra is the plant from which the drug ephedrine was
originally isolated. Phenylpropanolamine and ephedrine have similar effects and side
effects.1 Ephedra, also called ma huang, is used in many herbal products including
supplements promoted for weight loss.
While interactions between phenylpropanolamine and ephedra have not been reported, it seems
likely that such interactions could occur. To prevent potential problems, people taking
phenylpropanolamine-containing products should avoid using ephedra/ephedrine-containing
products.
Interactions with Foods and Other Compounds
Caffeine
Phenylpropanolamine can increase blood pressure,2 a danger especially in people
with high blood pressure.3 In a
double-blind study of six healthy people, administration of caffeine and phenylpropanolamine
produced an additive increase in blood pressure.4 Additionally, in a study of 16
healthy people, phenylpropanolamine plus caffeine resulted in higher serum caffeine levels
than when caffeine was given alone.5
Caffeine is found in coffee, tea, soft drinks, chocolate,
guaraná (Paullinia cupana), nonprescription drugs, and supplement
products containing caffeine or guaraná. People taking phenylpropanolamine-containing
products can minimize the interaction with caffeine by limiting or avoiding caffeine.
References:
1. Threlkeld DS, ed. Respiratory Drugs, Sympathomimetics. In Facts
and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, May 1994,
173a–3h.
2. Hoffman BB, Lefkowitz RL. Catecholamines, sympathomimetic drugs, and
adrenergic receptor antagonists. In Goodman and Gilman’s The Pharmcological Basis of
Therapeutics, 9th ed. New York: McGraw-Hill, 1996, 223.
3. Threlkeld DS, ed. Respiratory Drugs, Sympathomimetics. In Facts
and Comparisons Drug Information. St. Louis, MO: Facts and Comparisons, Apr 1993,
173a–3h.
4. Brown NJ, Ryder D, Branch RA. A pharmacodynamic interaction between
caffeine and phenylpropanolamine. Clin Pharmacol Ther 1991;50:363–71.
5. Lake CR, Rosenberg DB, Gallant S, et al. Phenylpropanolamine increases
plasma caffeine levels. Clin Pharmacol Ther 1990;47:675–85.
Copyright © 2002 Healthnotes, Inc. All rights
reserved. www.healthnotes.com
Please read the disclaimer
about the limitations of the information provided here. Do NOT rely solely on the information
in this article.
Learn more about Healthnotes, the company.
Learn more about the authors of
Safetychecker.
The information presented in Healthnotes is for informational
purposes only. It is based on scientific studies (human, animal, or in vitro),
clinical experience, or traditional usage as cited in each article. The results reported may
not necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over-the-counter medication is also available. Consult your doctor,
practitioner, and/or pharmacist for any health problem and before using any supplements or
before making any changes in prescribed medications. Information expires December 2003.
|